• Oculis management commentary reported a 24% narrower net loss of CHF 57.06 million for the nine months ended September 30, 2026.
• Warrant valuation gains and favorable currency movements drove the improvement, outweighing higher operating expenses.
• General and administrative expenses rose 39% to CHF 25.08 million, primarily reflecting higher share-based compensation.
• Research and development expenses increased 1% to CHF 44.38 million as higher personnel costs outweighed lower external service expenses.
• Operating cash outflow increased 10% to CHF 54.53 million; cash, cash equivalents and short-term financial assets totaled CHF 210.3 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oculis Holding AG published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-445380), on November 03, 2026, and is solely responsible for the information contained therein.